A wide variety of disturbances of cell membrane handling of sodium have been documented in hypertension; moreover, cell membrane structure itself appears to differ, and more recently calcium affinity and extrusion have been found to be abnormal.5 It seems most likely that a fundamental disturbance of membrane structure or function, or both, genetically determined, underlies them. Whether this is present in the cells secreting catecholamines or merely in the target organs, thereby altering their response, is uncertain. Nevertheless, the full effects of noradrenaline on cell membrane function in hypertension remain to be elucidated: in addition, the effects of catecholamines on sodium transport will have to be considered more carefully if artefactual findings are to be avoided. 
Introduction
Somatostatin suppresses many of the gut peptides implicated in the control of secretory and motor activity of the gastrointestinal tract. These actions no doubt contribute to its recently described efficacy in the treatment of patients with bleeding peptic ulcers, the carcinoid syndrome, and enteric fistulas. Its use in the control of diarrhoea has been virtually confined to patients with peptide secretory tumours,1 although it has been shown to be beneficial in a few patients with profuse diarrhoea due to pseudoobstruction2 and the short bowel syndrome.3 One of the main factors limiting its therapeutic use is its short half life (two to three minutes), and therefore attempts have been made to develop longer acting analogues. We report the successful use of such a drug (SMS 201-995, Sandoz Ltd) to control the output of effluent from a patient with life threatening ileostomy diarrhoea of unknown aetiology.
Case report
A 46 year old woman with Crohn's disease for which she had undergone colectomy and ileorectal anastomosis in November 1980 (35 cm of distal ileum resected) represented in December 1982 with an enterocutaneous fistula due to recurrent disease proximal to the anastomosis. Conservative treatment failed to heal the fistula, and in January 1984 she underwent resection of the fistula, ileorectal anastomosis, and distal ileum (30 cm). A new ileorectal anastomosis was fashioned and defunctioned by creating an end ileostomy. At laparotomy the rest of the small bowel was macroscopically normal.
She recovered from the operation, but during the next four months she had a persistently high ileostomy output, passing four to six litres of watery fluid per 24 hours while receiving oral nutrition and two to three litres when starved. There was no evidence of adaptation of the ileostomy, and the diarrhoea remained unresponsive to conventional drug treatment. She required continuous parenteral nutrition, but despite treatment she continued to lose weight and developed electrolyte disturbances that prevented her from leaving hospital. Investigations failed to disclose a cause for the diarrhoea: in particular, the profile of gut hormones (including vasoactive intestinal polypeptide) was normal.
Four months after formation of the ileostomy she was given infusions of SMS 201-995 (25 ,ug/h) and placebo (isotonic saline 125 ml/h), each over 24 hours, on a double blind basis. During each infusion gastric emptying and transit of a standard meal through the small bowel were measured,4 and simultaneously the amounts of nutrient and electrolyte excreted during the study period (defined as from the start of ingestion of the meal to a point when two consecutive ileostomy samples contained less than 50 of marker) were determined. Table I shows the ileostomy output, electrolyte content, and transit data. The excretion of nitrogen, fat, and glucose remained unchanged while she received the drug. In a separate study the output volume and electrolyte content over 24 hours were determined while she received a standard hospital diet during infusion with drug and placebo (table II) . After the drug was stopped there was no rebound phenomenon. Treatment with SMS 201-995 was then started, 50 ,ug being given subcutaneously every 12 hours. This reduced her ileostomy output to 2 0-2 5 litres/24 hours with a normal diet, the effluent becoming semiformed. There were no side effects. Parenteral fluids were stopped and she was discharged from hospital. One month later she was still taking SMS 201-995; she felt well, the volume of her ileostomy output remained at 2-0-2 5 litres/24 hours, and she had gained 2 5 kg in weight since the start of the treatment.
Discussion
SMS 201-995 dramatically reduced the life threatening ileostomy diarrhoea experienced by this patient and enabled her to return to a fairly normal life. The cause of the profuse output was not entirely clear. The excessive content of water and electrolytes in the effluent could not be explained entirely by the length of ileum resected or subsequent malabsorption of fat. A disturbance of the intestinal transport mechanism of fluid is partly implicated because an output of two to three litres per 24 hours persisted during starvation. Thus a combination of secretory, malabsorption, and osmotic factors appears to have been the cause. Somatostatin enhances absorption of water and electrolytes in normal ileum,5 and presumably this was the mode of action in our patient. Interestingly, although water and electrolyte outputs were reduced during treatment, the amounts of fat and glucose excreted were not affected. Although somatostatin may slow gastric emptying, this was not the case in our patient. The prolongation of transit through the small bowel was probably secondary to the drug's effect on the transport of fluid, although a primary effect on motility cannot be ruled out.
Our results suggest that this drug might be used to treat more patients with secretory diarrhoea in addition to those with rare gastrointestinal tumours secreting hormones. This prospect is exciting, but obviously further data accrued from prospective controlled trials are required. Caution is also necessary. As the drug can inhibit secretion of a wide range of hormones including insulin and growth hormone it may have long term metabolic sequelae, and careful follow up in specialised units will be needed. 
